Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.545 USD | +0.71% | -3.65% | -4.68% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.68% | 401M | |
+9.74% | 118B | |
+10.44% | 106B | |
-11.01% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.66% | 15.97B | |
+6.91% | 14.03B | |
+17.43% | 11.67B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating